cholestyramine resin has been researched along with pravastatin in 56 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (pravastatin) | Trials (pravastatin) | Recent Studies (post-2010) (pravastatin) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 3,575 | 1,036 | 816 |
| Protein | Taxonomy | cholestyramine resin (IC50) | pravastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.1452 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0056 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0056 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0254 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.36) | 18.7374 |
| 1990's | 45 (80.36) | 18.2507 |
| 2000's | 8 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itakura, H | 1 |
| Clifton, P; Janus, ED; Nestel, PJ; Parfitt, A; Simons, J; Simons, LA | 1 |
| Arai, H; Hara, S; Ishii, K; Kita, T; Kume, N; Nagano, Y; Otani, H; Ueda, Y; Yokode, M | 1 |
| Alessandri, C; Peverini, F | 1 |
| Fukami, M; Fukushige, J; Itakura, H; Ito, T; Kuroda, M; Matsumoto, A; Nara, F; Shiomi, M; Tsujita, Y; Watanabe, Y | 1 |
| Jacob, BG; Möhrle, W; Richter, WO; Schwandt, P | 1 |
| Aviram, M; Brook, GJ; Hoffman, R | 1 |
| Betteridge, DJ; Bhatnager, D; Bing, RF; Durrington, PN; Evans, GR; Flax, H; Jay, RH; Lewis-Barned, N; Mann, J; Matthews, DR | 1 |
| Mimura, K; Yukawa, S | 1 |
| Dammann, HG; Ditschuneit, H; Ditschuneit, HH; Dreyer, M | 1 |
| Angelin, B | 1 |
| Berrocal, M; Chang, S; Drexler, A; Gordon, B; Kavanagh, M; Robertson, C; Yannuzzi, L | 1 |
| Angelin, B; Berglund, L; Dallner, G; Elmberger, PG; Eriksson, M; Kalén, A; Lund, E; Reihnér, E | 1 |
| Betteridge, DJ; Jay, RH; Katz, M; McGarrigle, HH; Reckless, JP; Stirling, C; Sturley, RH | 1 |
| Angelin, B; Berglund, L; Bondjers, G; Eriksson, M; Fager, G; Olofsson, SO; Wiklund, O | 1 |
| Batta, A; Ness, G; Nguyen, LB; Packin, V; Salen, G; Shefer, S; Shore, V; Tanaka, RD; Thomas, P | 1 |
| Bard, JM; Douste-Blazy, P; Fruchart, JC; Parra, HJ | 1 |
| Maher, VM; Thompson, GR | 1 |
| Brescia, D; DeVault, AR; Ivashkiv, E; Pan, HY; Swites, BJ; Whigan, D; Willard, DA | 1 |
| Arai, M; Fukami, M; Fukushige, J; Ito, T; Kuroda, M; Shiomi, M; Tamura, A; Tsujita, Y; Watanabe, Y | 1 |
| Angelin, B; Berglund, L; Bondjers, G; Eriksson, M; Fager, G; Lindén, T; Olofsson, SO; Sjöberg, A; Wiklund, O | 1 |
| Kurota, M; Maeda, H; Matsuda, T; Miyaho, S; Morikawa, K; Nakai, T; Oida, K; Takahashi, S; Takai, H; Tamai, T | 1 |
| Bimmermann, A; Schleicher, J; Schwartzkopff, W | 1 |
| Betteridge, DJ; Jay, RH; Rampling, MW | 1 |
| Freudenberger, JS; Lee, LY; Mosley, ST; Schafer, BL; Tanaka, RD | 1 |
| Arai, H; Ishii, K; Kawai, C; Kita, T; Kume, N; Nagano, Y; Otani, H; Ueda, Y; Yokode, M | 1 |
| Ishii, K; Kawai, C; Kita, T; Kume, N; Mikami, A; Nagano, Y; Yokode, M | 1 |
| Reynolds, GA | 1 |
| Ebisuno, S; Isohashi, F; Nakanishi, Y; Sakamoto, Y | 1 |
| Jacob, BG; Richter, WO; Schwandt, P | 1 |
| Bowler, A; Elsegood, CL; Mamo, JC; Redgrave, TG | 1 |
| Gibson, CM; Pasternak, RC; Rosner, B; Sacks, FM; Stone, PH | 1 |
| Angelin, B; Berglund, L; Bondjers, G; Eggertsen, G; Eriksson, M; Lindén, T; Olofsson, SO; Wiklund, O | 1 |
| Dobs, AS; Goldberg, A; Guccione, M; Hoover, DR; Prasad, M | 1 |
| Wendelhag, I; Wiklund, O; Wikstrand, J | 1 |
| Kamata, K; Kasuya, Y; Suenaga, H; Sugiura, M | 1 |
| Dotti, MT; Federico, A; Lindenthal, B; Lütjohann, D; Simatupang, A; von Bergmann, K | 1 |
| Bambauer, R; Müller, UA; Schiel, R | 1 |
| Hidaka, H; Kashiwagi, A; Kawabata, T; Kikkawa, R; Kojima, H; Konaka, K; Nakamura, T; Shigeta, Y | 1 |
| Corrigan, F | 1 |
| Bönner, G | 1 |
| Ito, MK; Shabetai, R | 1 |
| Ikeda, K; Michihara, A; Nara, Y; Sawamura, M; Yamori, Y | 1 |
| Eriksson, M; Hådell, K; Holme, I; Kjellström, T; Walldius, G | 1 |
| Higashikata, T; Inazu, A; Kajinami, K; Koizumi, J; Mabuchi, H; Yagi, K | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Linderer, T; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Fukui, T; Iwahori, A; Iwama, M; Nakamoto, M; Takahashi, N | 1 |
| El-Sohemy, A | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Kersting, F; Selenka, A; Walch, S | 1 |
| Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
| Mishra, TK; Routray, S | 1 |
| Asaka, M; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Miura, T; Obara, S; Tanaka, J; Tsutsumi, Y; Yamato, H | 1 |
| Plans-Rubió, P | 1 |
2 review(s) available for cholestyramine resin and pravastatin
| Article | Year |
|---|---|
[Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
Topics: Adult; Animals; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Guinea Pigs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Pravastatin; Rats; Risk Factors; Simvastatin; Time Factors | 1992 |
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
19 trial(s) available for cholestyramine resin and pravastatin
| Article | Year |
|---|---|
Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Safety; Treatment Outcome; Triglycerides | 1992 |
Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
Topics: Adolescent; Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Pravastatin; Treatment Outcome; Triglycerides | 1992 |
[Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Female; Gemfibrozil; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Pravastatin; Triglycerides | 1991 |
Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia.
Topics: Adrenal Glands; Cholestyramine Resin; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Gonads; Humans; Hydrocortisone; Hyperlipoproteinemia Type II; Male; Pravastatin; Sex Hormone-Binding Globulin; Steroids | 1991 |
HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Naphthalenes; Phenotype; Pravastatin; Simvastatin; Time Factors | 1990 |
Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.
Topics: Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Phospholipids; Pravastatin; Randomized Controlled Trials as Topic; Triglycerides | 1990 |
Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels.
Topics: Adult; Aged; Alanine Transaminase; Anticholesteremic Agents; Apolipoproteins; Aspartate Aminotransferases; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Naphthalenes; Pravastatin; Randomized Controlled Trials as Topic; Triglycerides | 1990 |
[Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
Topics: Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Pravastatin; Triglycerides | 1990 |
Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment.
Topics: Adult; Anticholesteremic Agents; Blood Viscosity; Cholestyramine Resin; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Middle Aged; Naphthalenes; Pravastatin; Rheology | 1990 |
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group.
Topics: Anticholesteremic Agents; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Gemfibrozil; Humans; Lipids; Male; Middle Aged; Niacin; Pravastatin; Treatment Outcome | 1994 |
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy.
Topics: Apolipoproteins E; Cholestyramine Resin; Double-Blind Method; Humans; Hyperlipoproteinemia Type II; Lipids; Phenotype; Pravastatin; Treatment Outcome | 1993 |
Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Creatine Kinase; Double-Blind Method; Drug Combinations; Female; Humans; Hypercholesterolemia; Liver; Male; Middle Aged; Placebos; Pravastatin; Safety; Triglycerides | 1993 |
Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs.
Topics: Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Double-Blind Method; Humans; Hyperlipidemias; Lipoprotein(a); Lovastatin; Male; Middle Aged; Pravastatin; Time Factors; Triglycerides | 1995 |
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life | 1995 |
Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Triglycerides | 1997 |
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Patient Compliance; Pravastatin; Primary Health Care; Sex Factors; Sweden; Treatment Outcome | 1998 |
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Prospective Studies; Treatment Outcome | 1999 |
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome | 2000 |
Effects of cholestyramine on vitamin E levels in patients treated with statins.
Topics: Adult; Aged; Anticholesteremic Agents; Antioxidants; Cholesterol, LDL; Cholestyramine Resin; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Lovastatin; Male; Middle Aged; Naphthalenes; Pravastatin; Simvastatin; Vitamin E | 2000 |
35 other study(ies) available for cholestyramine resin and pravastatin
| Article | Year |
|---|---|
[Treatment of hyperlipidemia].
Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dietary Fiber; Energy Intake; Female; Humans; Hyperlipidemias; Male; Niceritrol; Pravastatin; Probucol | 1992 |
The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
Topics: Animals; Apolipoproteins B; Cholesterol Esters; Cholestyramine Resin; Coronary Artery Disease; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Mice; Oxidation-Reduction; Pravastatin; Probucol; Rabbits; Receptors, LDL; RNA, Messenger | 1992 |
Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits.
Topics: Adrenal Glands; Animals; Cholesterol, LDL; Cholestyramine Resin; Drug Synergism; Hyperlipidemias; Intestinal Mucosa; Intestines; Liver; Male; Pravastatin; Rabbits; Receptors, LDL; RNA, Messenger | 1992 |
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Pravastatin; Time Factors; Triglycerides | 1992 |
Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.
Topics: Adult; Animals; Bezafibrate; Cells, Cultured; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Esterification; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Malondialdehyde; Mice; Middle Aged; Pravastatin; Vitamin E | 1992 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidney Failure, Chronic; Niceritrol; Pantetheine; Pravastatin; Probucol; Vitamin E | 1991 |
Regulation of hepatic cholesterol metabolism in man.
Topics: Cholelithiasis; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Naphthalenes; Pravastatin; Receptors, LDL | 1991 |
The effects of lipid lowering on diabetic retinopathy.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Dietary Fats; Female; Humans; Hyperlipidemias; Male; Middle Aged; Pravastatin; Triglycerides; Visual Acuity | 1991 |
Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Dolichols; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Mevalonic Acid; Middle Aged; Pravastatin; Ubiquinone | 1991 |
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins A; Cholestyramine Resin; Coronary Disease; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Naphthalenes; Pravastatin; Receptors, LDL | 1990 |
Purification of cholesterol 7 alpha-hydroxylase from human and rat liver and production of inhibiting polyclonal antibodies.
Topics: Animals; Antibodies; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Cholestyramine Resin; Chromatography; Cytochrome P-450 Enzyme System; Electrophoresis, Polyacrylamide Gel; Heptanoic Acids; Humans; Immunoblotting; Isoenzymes; Male; Microsomes, Liver; Molecular Weight; Naphthalenes; Pravastatin; Rats; Rats, Inbred Strains; Starvation; Steroid Hydroxylases | 1990 |
Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins A; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Bile Acids and Salts; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Evaluation; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Naphthalenes; Pravastatin; Random Allocation; Triglycerides | 1990 |
Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine.
Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Coronary Disease; Heptanoic Acids; Naphthalenes; Phospholipids; Pravastatin; Rabbits; Triglycerides; Xanthomatosis | 1990 |
[A case of familial hypercholesterolemia associated with nephrotic syndrome].
Topics: Cholestyramine Resin; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Middle Aged; Naphthalenes; Nephrotic Syndrome; Pravastatin; Prednisolone; Probucol | 1990 |
Purification and regulation of mevalonate kinase from rat liver.
Topics: Amino Acids; Animals; Anticholesteremic Agents; Cholestyramine Resin; Chromatography, Affinity; Chromatography, Gel; Chromatography, Ion Exchange; Female; Fluorides; Heptanoic Acids; Homeostasis; Hydroxymethylglutaryl CoA Reductases; Kinetics; Liver; Lovastatin; Molecular Weight; Naphthalenes; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Pravastatin; Rats; Rats, Inbred Strains; Reference Values | 1990 |
Lipoproteins and atherosclerosis.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cholestyramine Resin; Disease Models, Animal; Foam Cells; Heptanoic Acids; Hyperlipidemia, Familial Combined; Lipoproteins, LDL; Liver; Macrophages; Mice; Naphthalenes; Pravastatin; Probucol; Rabbits; Receptors, Cell Surface; Receptors, Lipoprotein | 1990 |
Induction of mRNA for low-density lipoprotein receptors in heterozygous Watanabe heritable hyperlipidemic rabbits treated with CS-514 (Pravastatin) and cholestyramine.
Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Heptanoic Acids; Heterozygote; Hyperlipoproteinemia Type II; Liver; Male; Naphthalenes; Pravastatin; Rabbits; Receptors, LDL; RNA, Messenger | 1989 |
Rational therapy of familial hypercholesterolemia.
Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Naphthalenes; Pravastatin; Rabbits; Receptors, LDL | 1989 |
Acetyl-CoA hydrolase: relation between activity and cholesterol metabolism in rat.
Topics: Acetyl-CoA Hydrolase; Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibric Acid; Cytosol; Diabetes Mellitus, Experimental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Naphthalenes; Pravastatin; Rats; Thiolester Hydrolases | 1988 |
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Pravastatin; Triglycerides | 1993 |
Clearance of chylomicron-like lipid emulsions is increased in normal rabbits but not in heterozygous Watanabe heritable hyperlipidaemic rabbits following treatment with cholestyramine or pravastatin.
Topics: Analysis of Variance; Animals; Bile Acids and Salts; Cholestyramine Resin; Chylomicrons; Fat Emulsions, Intravenous; Heterozygote; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; Metabolic Clearance Rate; Pravastatin; Rabbits | 1994 |
Intima-media thickness after cholesterol lowering in familial hypercholesterolemia. A three-year ultrasound study of common carotid and femoral arteries.
Topics: Anticholesteremic Agents; Carotid Artery, Common; Cholesterol; Cholestyramine Resin; Female; Femoral Artery; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Tunica Intima; Tunica Media; Ultrasonography | 1995 |
[Effect of cholestyramine on angiopathies in cholesterol-fed mice and diabetic mice].
Topics: Animals; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypercholesterolemia; Male; Mice; Mice, Inbred ICR; Pravastatin; Vascular Diseases; Vasodilation | 1995 |
Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Circadian Rhythm; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Mevalonic Acid; Middle Aged; Pravastatin; Reproducibility of Results; Simvastatin; Xanthomatosis, Cerebrotendinous | 1996 |
Effects of an HMG-CoA reductase inhibitor, pravastatin, and bile sequestering resin, cholestyramine, on plasma plant sterol levels in hypercholesterolemic subjects.
Topics: Acyl Coenzyme A; Adult; Anticholesteremic Agents; Cholestyramine Resin; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Phytosterols; Pravastatin | 1995 |
Lipid-lowering drugs and mortality.
Topics: Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Pravastatin; Treatment Outcome | 1997 |
[Care Study. Secondary prevention after myocardial infarct in moderately elevated total cholesterol].
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Diet, Fat-Restricted; Humans; Hyperlipidemias; Myocardial Infarction; Pravastatin; Risk Factors; Survival Rate | 1997 |
Purification and characterization of two mevalonate pyrophosphate decarboxylases from rat liver: a novel molecular species of 37 kDa.
Topics: Animals; Anticholesteremic Agents; Carboxy-Lyases; Cholesterol; Cholestyramine Resin; Enzyme Induction; Glycosylation; Hydrogen-Ion Concentration; Immunoblotting; Immunohistochemistry; Isoelectric Point; Isoenzymes; Kinetics; Liver; Male; Molecular Weight; Oligosaccharides; Pravastatin; Rats; Rats, Inbred WKY | 1997 |
Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia.
Topics: Adult; Aged; Anion Exchange Resins; Anticholesteremic Agents; Bile; Cholestyramine Resin; Drug Therapy, Combination; Female; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Pravastatin; Receptors, LDL; Treatment Outcome | 1998 |
cDNA-derived amino acid sequence of acetoacetyl-CoA synthetase from rat liver.
Topics: Amino Acid Sequence; Animals; Base Sequence; Cholestyramine Resin; Coenzyme A Ligases; Diet; DNA, Complementary; Female; Liver; Molecular Sequence Data; Pravastatin; Rats; Rats, Sprague-Dawley; Sequence Homology, Amino Acid | 2000 |
Statin drugs and the risk of fracture.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cholestyramine Resin; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Pravastatin; Risk; Transforming Growth Factor beta | 2000 |
Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
Topics: Anticholesteremic Agents; Bezafibrate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Female; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Male; Myocardial Infarction; Pravastatin; Treatment Outcome | 1999 |
Current perspectives on statins.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Coronary Artery Disease; Female; Humans; India; Lovastatin; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin | 2003 |
Rhabdomyolysis caused by distigmine bromide.
Topics: Aged; Anticholesteremic Agents; Cholestyramine Resin; Drug Interactions; Female; Humans; Muscle, Skeletal; Pravastatin; Pyridinium Compounds; Rhabdomyolysis; Urinary Retention | 2003 |
Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Meta-Analysis as Topic; Pravastatin; Pyrroles; Risk Factors; Simvastatin; Spain | 2006 |